Expanding Buprenorphine Use in Primary Care: Changing the Culture.
作者信息
Leiser Abraham, Robles Maria
机构信息
School of Medicine, Indiana University, Bloomington, IN, USA.
Department of Medicine, School of Medicine, Indiana University, Bloomington, IN, USA.
出版信息
Perm J. 2022 Jun 29;26(2):177-180. doi: 10.7812/TPP/21.203. Epub 2022 Jun 15.
Abstract
摘要
相似文献
1
Expanding Buprenorphine Use in Primary Care: Changing the Culture.扩大丁丙诺啡在初级保健中的应用：改变文化。
Perm J. 2022 Jun 29;26(2):177-180. doi: 10.7812/TPP/21.203. Epub 2022 Jun 15.
2
Use and misuse of opioid agonists in opioid addiction.阿片类药物成瘾中阿片类激动剂的使用和滥用。
Cleve Clin J Med. 2017 May;84(5):377-384. doi: 10.3949/ccjm.84a.16091.
3
Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.初级保健中青少年阿片类物质使用障碍的药物治疗
Pediatr Rev. 2018 Jan;39(1):43-45. doi: 10.1542/pir.2017-0153.
4
Primary care management of opioid dependence: the addition of CBT gives no extra benefit compared to standard physician management alone.
Evid Based Ment Health. 2013 Aug;16(3):76. doi: 10.1136/eb-2013-101253. Epub 2013 Apr 24.
5
Does the advent of depot therapy represent a step change in our understanding of opioid use disorder and its treatment?储库型疗法的出现是否代表了我们对阿片类药物使用障碍及其治疗的理解的重大转变？
Drug Alcohol Rev. 2024 Jan;43(1):261-264. doi: 10.1111/dar.13732. Epub 2023 Jul 31.
6
Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period.因阿片类物质使用障碍而维持使用丁丙诺啡治疗的患者，在围手术期应继续使用丁丙诺啡。
Pain Med. 2019 Mar 1;20(3):425-428. doi: 10.1093/pm/pny019.
7
Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis?在初级保健中筛查阿片类药物使用障碍会增加新诊断患者的比例吗？
Ann Intern Med. 2023 Oct;176(10):1431-1433. doi: 10.7326/M23-1369.
8
Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.丁丙诺啡用于治疗一名患有抑郁症和酒精依赖的处方阿片类药物成瘾患者。
Am J Psychiatry. 2011 Jul;168(7):675-9. doi: 10.1176/appi.ajp.2010.10060879.
9
Treating Adolescent Opioid Use Disorder in Primary Care.在初级保健中治疗青少年阿片类物质使用障碍
JAMA Pediatr. 2024 Apr 1;178(4):414-416. doi: 10.1001/jamapediatrics.2023.6493.
10
The Implementation of a Clinic-Based Opioid Review Board to Address High-Risk Opioid Prescribing in Primary Care.实施基于诊所的阿片类药物审查委员会以解决初级保健中高风险阿片类药物处方问题。
Ann Fam Med. 2021 Nov-Dec;19(6):563. doi: 10.1370/afm.2738.
引用本文的文献
1
Evaluating Barriers to Opioid Use Disorder Treatment From Patients' Perspectives.从患者角度评估阿片类物质使用障碍治疗的障碍
PRiMER. 2024 Feb 19;8:11. doi: 10.22454/PRiMER.2024.458349. eCollection 2024.
2
Integrating Opioid Use Disorder Treatment Into Primary Care Settings.将阿片类药物使用障碍治疗纳入初级保健环境中。
JAMA Netw Open. 2023 Aug 1;6(8):e2328627. doi: 10.1001/jamanetworkopen.2023.28627.
本文引用的文献
1
"You are not clean until you're not on anything": Perceptions of medication-assisted treatment in rural Appalachia.“在停止使用任何药物之前，你都不算戒毒成功”：阿巴拉契亚农村地区对药物辅助治疗的认知
Int J Drug Policy. 2020 Nov;85:102704. doi: 10.1016/j.drugpo.2020.102704. Epub 2020 Mar 12.
2
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.不同阿片类药物使用障碍治疗途径的疗效比较。
JAMA Netw Open. 2020 Feb 5;3(2):e1920622. doi: 10.1001/jamanetworkopen.2019.20622.
3
Buprenorphine Treatment Divide by Race/Ethnicity and Payment.美沙酮治疗按种族/民族和支付方式划分。
JAMA Psychiatry. 2019 Sep 1;76(9):979-981. doi: 10.1001/jamapsychiatry.2019.0876.
4
Treating opioid use disorder in primary care.在初级保健中治疗阿片类药物使用障碍。
Can Fam Physician. 2019 Feb;65(2):117.
5
Why aren't physicians prescribing more buprenorphine?为什么医生没有开出更多的丁丙诺啡？
J Subst Abuse Treat. 2017 Jul;78:1-7. doi: 10.1016/j.jsat.2017.04.005. Epub 2017 Apr 12.
6
Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America.推卸责任：美国中产阶级中的丁丙诺啡开处方者、成瘾治疗与处方监测
Transcult Psychiatry. 2016 Aug;53(4):465-87. doi: 10.1177/1363461516660884. Epub 2016 Aug 3.
7
Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.基于办公室的丁丙诺啡阿片类药物治疗（OBOT-B）：马萨诸塞州协作护理模式在社区卫生中心的全州实施情况
J Subst Abuse Treat. 2016 Jan;60:6-13. doi: 10.1016/j.jsat.2015.06.010. Epub 2015 Jun 26.
8
National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.国家和州对阿片类激动剂药物辅助治疗的需求及能力
Am J Public Health. 2015 Aug;105(8):e55-63. doi: 10.2105/AJPH.2015.302664. Epub 2015 Jun 11.
9
Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.医疗补助计划中患有阿片类药物依赖或滥用的成员复发及更高成本的风险因素：阿片类激动剂、合并症和治疗史
J Subst Abuse Treat. 2015 Oct;57:75-80. doi: 10.1016/j.jsat.2015.05.001. Epub 2015 May 7.
10
Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.家庭医生采用丁丙诺啡维持疗法的障碍分析。
Rural Remote Health. 2015;15:3019. Epub 2015 Feb 4.
Zotero 插件